Clinical Trial: A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers

U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279636) titled 'A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers' on Nov. 29.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of Alpha-0261 tablets after single oral administration in healthy adult volunteers.

Study Start Date: July 21

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: Alpha-0261

Oral, tablet

OTHER: Placebo

Oral, tablet

Recruitment Status: RECRUITING

Sponsor: AlphaMol Science Ltd. (Shanghai)

Disclaimer: Curated by HT Syndication....